• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐碳青霉烯类肠杆菌科细菌定植的危险因素分析及预测模型建立:一项回顾性队列研究

Risk Factors Analysis and Prediction Model Establishment for Carbapenem-Resistant Enterobacteriaceae Colonization: A Retrospective Cohort Study.

作者信息

Guo Xiaolan, Wu Dansen, Chen Xiaoping, Lin Jing, Chen Jialong, Wang Liming, Shi Songjing, Yang Huobao, Liu Ziyi, Hong Donghuang

机构信息

Department of Critical Care Medicine, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian, People's Republic of China.

Computer Science and Mathematics, Fujian University of Technology, Fuzhou, Fujian, People's Republic of China.

出版信息

Infect Drug Resist. 2024 Oct 28;17:4717-4726. doi: 10.2147/IDR.S485915. eCollection 2024.

DOI:10.2147/IDR.S485915
PMID:39494229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11529608/
Abstract

PURPOSE

The objective of this study was to identify the risk factors associated with Carbapenem-resistant Enterobacteriaceae (CRE) colonization in intensive care unit (ICU) patients and to develop a predictive risk model for CRE colonization.

PATIENTS AND METHODS

In this study, 121 ICU patients from Fujian Provincial Hospital were enrolled between January 2021 and July 2022. Based on bacterial culture results from rectal and throat swabs, patients were categorized into two groups: CRE-colonized (n = 18) and non-CRE-colonized (n = 103). To address class imbalance, Synthetic Minority Over-sampling Technique (SMOTE) was applied. Statistical analyses including T-tests, Chi-square tests, and Mann-Whitney -tests were employed to compare differences between the groups. Feature selection was performed using Lasso regression and Random Forest algorithms. A Logistic regression model was then developed to predict CRE colonization risk, and the results were presented in a nomogram.

RESULTS

After applying SMOTE, the dataset included 198 CRE-colonized patients and 180 non-CRE-colonized patients, ensuring balanced groups. The two groups were comparable in most clinical characteristics except for diabetes, previous emergency department admission, and abdominal infection. Eight independent risk factors for CRE colonization were identified through Random Forest, Lasso regression, and Logistic regression, including Acute Physiology and Chronic Health Evaluation (APACHE) II score > 16, length of hospital stay > 31 days, female gender, previous carbapenem antibiotic exposure, skin infection, multi-site infection, immunosuppressant exposure, and tracheal intubation. The risk prediction model for CRE colonization demonstrated high accuracy (87.83%), recall rate (89.9%), precision (85.6%), and an AUC value of 0.877. Patients were categorized into low-risk (0-90 points), medium-risk (91-160 points), and high-risk (161-381 points) groups, with corresponding CRE colonization rates of 1.82%, 7.14%, and 58.33%, respectively.

CONCLUSION

This study identified independent risk factors for CRE colonization and developed a predictive model for assessing the risk of CRE colonization.

摘要

目的

本研究的目的是确定重症监护病房(ICU)患者中与耐碳青霉烯类肠杆菌科细菌(CRE)定植相关的风险因素,并建立CRE定植的预测风险模型。

患者与方法

在本研究中,纳入了2021年1月至2022年7月期间福建省立医院的121例ICU患者。根据直肠和咽喉拭子的细菌培养结果,将患者分为两组:CRE定植组(n = 18)和非CRE定植组(n = 103)。为了解决类别不平衡问题,应用了合成少数过采样技术(SMOTE)。采用T检验、卡方检验和曼-惠特尼检验等统计分析方法比较两组之间的差异。使用套索回归和随机森林算法进行特征选择。然后建立逻辑回归模型来预测CRE定植风险,并将结果以列线图的形式呈现。

结果

应用SMOTE后,数据集包括198例CRE定植患者和180例非CRE定植患者,确保了组间平衡。除糖尿病、既往急诊科就诊和腹部感染外,两组在大多数临床特征上具有可比性。通过随机森林、套索回归和逻辑回归确定了8个CRE定植的独立风险因素,包括急性生理与慢性健康状况评估(APACHE)II评分> 16、住院时间> 31天、女性、既往碳青霉烯类抗生素暴露、皮肤感染、多部位感染、免疫抑制剂暴露和气管插管。CRE定植的风险预测模型显示出较高的准确性(87.83%)、召回率(89.9%)、精确率(85.6%)和AUC值0.877。患者被分为低风险(0 - 90分)、中风险(91 - 160分)和高风险(161 - 381分)组,相应的CRE定植率分别为1.82%、7.14%和58.33%。

结论

本研究确定了CRE定植的独立风险因素,并建立了一个评估CRE定植风险的预测模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e1f/11529608/7816edc7cc6e/IDR-17-4717-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e1f/11529608/89fd52329984/IDR-17-4717-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e1f/11529608/62e7ca2b5c41/IDR-17-4717-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e1f/11529608/7816edc7cc6e/IDR-17-4717-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e1f/11529608/89fd52329984/IDR-17-4717-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e1f/11529608/62e7ca2b5c41/IDR-17-4717-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e1f/11529608/7816edc7cc6e/IDR-17-4717-g0003.jpg

相似文献

1
Risk Factors Analysis and Prediction Model Establishment for Carbapenem-Resistant Enterobacteriaceae Colonization: A Retrospective Cohort Study.耐碳青霉烯类肠杆菌科细菌定植的危险因素分析及预测模型建立:一项回顾性队列研究
Infect Drug Resist. 2024 Oct 28;17:4717-4726. doi: 10.2147/IDR.S485915. eCollection 2024.
2
Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study.碳青霉烯类耐药肠杆菌科细菌定植(CRE)与重症患者随后的感染风险及90天死亡率:一项观察性研究
PLoS One. 2017 Oct 12;12(10):e0186195. doi: 10.1371/journal.pone.0186195. eCollection 2017.
3
Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.重症患者中耐碳青霉烯类肠杆菌科细菌的定植与感染:与非携带者的回顾性匹配队列比较
J Hosp Infect. 2016 Sep;94(1):54-9. doi: 10.1016/j.jhin.2016.05.018. Epub 2016 Jun 6.
4
Increased Risk for Carbapenem-Resistant Enterobacteriaceae Colonization in Intensive Care Units after Hospitalization in Emergency Department.在急诊住院后,重症监护病房中耐碳青霉烯类肠杆菌科定植的风险增加。
Emerg Infect Dis. 2020 Jun;26(6):1156-1163. doi: 10.3201/eid2606.190965. Epub 2020 Jun 17.
5
Development of a risk prediction model for subsequent infection after colonization with carbapenem-resistant Enterobacterales: a retrospective cohort study.耐碳青霉烯类肠杆菌科细菌定植后后续感染风险预测模型的开发:一项回顾性队列研究
Antimicrob Resist Infect Control. 2024 Apr 24;13(1):46. doi: 10.1186/s13756-024-01394-5.
6
[Clinical characteristics of carbapenem-resistant infection in pediatric liver transplantation recipients].[儿童肝移植受者碳青霉烯类耐药感染的临床特征]
Zhonghua Er Ke Za Zhi. 2020 Aug 2;58(8):640-645. doi: 10.3760/cma.j.cn112140-20200316-00239.
7
Clinical Risk Factors and Microbiological and Intestinal Characteristics of Carbapenemase-Producing Colonization and Subsequent Infection.产碳青霉烯酶定植及后续感染的临床危险因素及微生物学和肠道特征。
Microbiol Spectr. 2022 Dec 21;10(6):e0190621. doi: 10.1128/spectrum.01906-21. Epub 2022 Nov 29.
8
Frequency of and risk factors for carbapenem-resistant .碳青霉烯类耐药肠杆菌科细菌的发生频率和危险因素。
J Med Microbiol. 2021 Feb;70(2). doi: 10.1099/jmm.0.001286.
9
Construction of a Risk Prediction Model for Subsequent Bloodstream Infection in Intestinal Carriers of Carbapenem-Resistant Enterobacteriaceae: A Retrospective Study in Hematology Department and Intensive Care Unit.耐碳青霉烯类肠杆菌科细菌肠道携带者后续血流感染风险预测模型的构建:血液科和重症监护病房的回顾性研究
Infect Drug Resist. 2021 Mar 2;14:815-824. doi: 10.2147/IDR.S286401. eCollection 2021.
10
The Impact of Modifying Empirical Antibiotic Therapy Based on Intestinal Colonization Status on Clinical Outcomes of Febrile Neutropenic Patients.基于肠道定植状态调整经验性抗生素治疗对发热性中性粒细胞减少患者临床结局的影响
Infect Chemother. 2021 Mar;53(1):63-74. doi: 10.3947/ic.2020.0111. Epub 2021 Jan 22.

引用本文的文献

1
Carbapenemase-Producing Colonization and the Risk of Carbapenemase-Producing Bacteremia in Hematopoietic Stem Cell Transplant Recipients.造血干细胞移植受者中碳青霉烯酶产生菌的定植及碳青霉烯酶产生菌血症的风险
Open Forum Infect Dis. 2025 Sep 2;12(9):ofaf516. doi: 10.1093/ofid/ofaf516. eCollection 2025 Sep.
2
Clinical characteristics, risk factors and prognosis of infection in patients with different states of immune function: a retrospective study.不同免疫功能状态患者感染的临床特征、危险因素及预后:一项回顾性研究
Front Cell Infect Microbiol. 2025 May 30;15:1539554. doi: 10.3389/fcimb.2025.1539554. eCollection 2025.

本文引用的文献

1
In-vitro activities of essential antimicrobial agents including aztreonam/avibactam, eravacycline, colistin and other comparators against carbapenem-resistant bacteria with different carbapenemase genes: A multi-centre study in China, 2021.2021 年中国多中心研究:包括阿维巴坦/氨曲南、依拉环素、黏菌素和其他对照药物在内的基本抗菌药物对不同碳青霉烯酶基因碳青霉烯耐药菌的体外活性。
Int J Antimicrob Agents. 2024 Nov;64(5):107341. doi: 10.1016/j.ijantimicag.2024.107341. Epub 2024 Sep 18.
2
Carbapenem-resistant Gram-negative bacteria (CR-GNB) in ICUs: resistance genes, therapeutics, and prevention - a comprehensive review.重症监护病房中的耐碳青霉烯类革兰氏阴性菌(CR-GNB):耐药基因、治疗和预防——全面综述。
Front Public Health. 2024 Mar 27;12:1376513. doi: 10.3389/fpubh.2024.1376513. eCollection 2024.
3
Clinical significance and burden of carbapenem-resistant Enterobacterales (CRE) colonization acquisition in hospitalized patients.住院患者中产碳青霉烯类耐药肠杆菌科(CRE)定植获得的临床意义和负担。
Antimicrob Resist Infect Control. 2023 Nov 20;12(1):129. doi: 10.1186/s13756-023-01323-y.
4
Risk Factors for Carbapenem-Resistant Colonization and the Effect on Clinical Outcomes and Prognosis in Allogeneic Hematopoietic Stem Cell Transplanted Patients.异基因造血干细胞移植患者耐碳青霉烯定植的危险因素及其对临床结局和预后的影响
Infect Drug Resist. 2023 Oct 25;16:6821-6831. doi: 10.2147/IDR.S424048. eCollection 2023.
5
An observational study on carbapenem-resistant Enterobacterales (CRE) colonisation and subsequent risk of infection in an adult intensive care unit (ICU) at a tertiary care hospital in India.印度一家三级护理医院成人重症监护病房(ICU)中耐碳青霉烯类肠杆菌科细菌(CRE)定植及后续感染风险的观察性研究。
Infect Prev Pract. 2023 Sep 30;5(4):100312. doi: 10.1016/j.infpip.2023.100312. eCollection 2023 Dec.
6
Who should be screened for carbapenemase-producing Enterobacterales and when? A systematic review.应该对哪些人进行产碳青霉烯酶肠杆菌科的筛查,以及何时进行筛查?系统评价。
J Hosp Infect. 2023 Dec;142:74-87. doi: 10.1016/j.jhin.2023.09.018. Epub 2023 Oct 5.
7
Epidemiology and Antimicrobial Resistance Patterns of Urinary Tract Infections: A Cross-Sectional Study from Southwestern Saudi Arabia.尿路感染的流行病学和抗菌药物耐药模式:来自沙特阿拉伯西南部的一项横断面研究。
Medicina (Kaunas). 2023 Aug 2;59(8):1411. doi: 10.3390/medicina59081411.
8
Carbapenem-resistant gram-negative bacterial infection in intensive care unit patients: Antibiotic resistance analysis and predictive model development.重症监护病房耐碳青霉烯类革兰阴性菌感染患者:抗生素耐药性分析及预测模型的建立。
Front Cell Infect Microbiol. 2023 Jan 30;13:1109418. doi: 10.3389/fcimb.2023.1109418. eCollection 2023.
9
The burden of carbapenem-resistant infection in a large Thai tertiary care hospital.泰国一家大型三级护理医院中耐碳青霉烯类感染的负担。
Front Pharmacol. 2022 Sep 2;13:972900. doi: 10.3389/fphar.2022.972900. eCollection 2022.
10
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.